EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of Antiplatelet Therapy in Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Endarterectomy within Coronary Artery Bypass Surgery

Ilir Balaj, Heinz Jakob, Ali Haddad iD, Fanar Mourad, Assad Haneya, Ebrahim Ali, Noura Ryadi, Matthias Thielmann iD, Arjang Ruhparwar, Sharaf-Eldin Shehada iD

Journal of Cardiovascular Development and Disease · 07.03.2023 · 10 (3) · 112

DOI: 10.3390/jcdd10030112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 07.03.2023. Verfasst von Ilir Balaj und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Centre, University Hospital Essen, University Duisburg-Essen, 45147…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background—Coronary endarterectomy (CEA) has been introduced to allow revascularization in end-stage coronary artery disease (CAD). After CEA, the injured remnants of the vessel’s media could result in fast neo intimal tissue ingrowth, which require an anti-proliferation agent (antiplatelet therapy (APT). We aimed to review outcomes of patients undergoing CEA within bypass surgery who received either single-APT (SAPT) or dual-APT (DAPT). Methods—We retrospectively evaluated 353 consecutive patients undergoing CEA within isolated coronary artery bypass grafting (CABG) in the period 01/2000–07/2019. After surgery, patients received either SAPT (n = 153), or DAPT (n = 200) for six months then lifelong SAPT. Endpoints included early, late survival, and freedom from major-adverse-cardiac and cerebrovascular events (MACCE), which were defined as incidence of stroke, myocardial infarction, need for coronary intervention (PCI or CABG) or death for any cause. Results—Patients’ mean age was 67 ± 9.3 years; they were predominantly male 88.1%. Both DAPT- and SAPT-groups had the same extent of CAD (mean SYNTAX-Score-II: 34.1 ± 11.6 vs. 34.4 ± 17.2, p = 0.91). Postoperatively, no difference between DAPT- and SAPT-groups was reported in the incidence of low-cardiac-output syndrome (5% vs. 9.8%, p = 0.16), revision for bleeding (5% vs. 6.5% p = 0.64), 30-day mortality (4.5% vs. 5.2%, p = 0.8) or MACCE (7.5% vs. 11.8%, p = 0.19). Imaging follow-up reported significantly higher CEA and total grafts patency (90% vs. 81.5% and 95% vs. 81%, p = 0.017) in DAPT patients. Late outcomes within 97.4 ± 67.4 months show lower incidence of overall mortality (19 vs. 51%, p < 0.001) and MACCE (24.5 vs. 58.2%, p < 0.001) in the DAPT patients when compared with SAPT patients. Conclusions—Coronary endarterectomy allows revascularization in end-stage CAD when the myocardium is still viable. The use of dual APT after CEA for at least six months seems to improve mid-to-long-term patency rates and survival, and reduced the incidence of major adverse cardiac and cerebrovascular events.

Schlagwörter

Stichwörter der Autor:innen

coronary artery endarterectomyend-stage coronary artery diseasemono and dual antiplatelet therapyviable myocardium

Autor:innen und Institutionen

  • Department of Thoracic and Cardiovascular Surgery, West German Heart and Vascular Centre, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.
  • Department of Anaesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.
  • Department of Cardiac and Vascular Surgery, Campus Kiel, University-Medical-Center Schleswig-Holstein, 24106 Kiel, Germany.

ORCID-Profile: Ali Haddad, Matthias Thielmann, Sharaf-Eldin Shehada

Zitieren

APA

Balaj, I., Jakob, H., Haddad, A., Mourad, F., Haneya, A., Ali, E., Ryadi, N., Thielmann, M., Ruhparwar, A., & Shehada, S. E. (2023). Role of Antiplatelet Therapy in Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Endarterectomy within Coronary Artery Bypass Surgery. Journal of Cardiovascular Development and Disease, 10(3), 112. https://doi.org/10.3390/jcdd10030112

Vancouver

Balaj I, Jakob H, Haddad A, Mourad F, Haneya A, Ali E, et al. Role of Antiplatelet Therapy in Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Endarterectomy within Coronary Artery Bypass Surgery. Journal of Cardiovascular Development and Disease. 2023;10(3):112. doi:10.3390/jcdd10030112

BibTeX
@article{Balaj2023,
  author = {Balaj, Ilir and Jakob, Heinz and Haddad, Ali and Mourad, Fanar and Haneya, Assad and Ali, Ebrahim and Ryadi, Noura and Thielmann, Matthias and Ruhparwar, Arjang and Shehada, Sharaf-Eldin},
  title = {Role of Antiplatelet Therapy in Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Endarterectomy within Coronary Artery Bypass Surgery},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2023},
  volume = {10},
  number = {3},
  pages = {112},
  doi = {10.3390/jcdd10030112}
}
Kostenlos starten →